BioSyent Inc. (TSXV:RX)
12.50
-0.10 (-0.79%)
Feb 2, 2026, 11:10 AM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 140.78 million as of February 3, 2026. Its market cap has increased by 7.94% in one year.
Market Cap
140.78M
Enterprise Value
118.28M
Revenue
42.18M
Ranking
n/a
PE Ratio
16.73
Stock Price
12.50
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 140.78M, an increase of 966.05%. That is a compound annual growth rate of 8.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 140.78M | -1.81% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 264.27M |
| Auxly Cannabis Group | 184.55M |
| Cannara Biotech | 167.62M |
| Ascend Wellness Holdings | 164.57M |
| Cardiol Therapeutics | 142.00M |
| HLS Therapeutics | 140.42M |
| Grown Rogue International | 139.97M |
| Charlotte's Web Holdings | 111.78M |